Literature DB >> 8689280

Peripheral pyogenic arthritis. A study of one hundred seventy-nine cases.

L Le Dantec1, F Maury, R M Flipo, S Laskri, B Cortet, B Duquesnoy, B Delcambre.   

Abstract

A retrospective medical record-based study of cases of peripheral pyogenic arthritis diagnosed in a rheumatology department between 1966 and 1993 was conducted. Of the 197 cases, 179 were evaluable. Pyogenic arthritis accounted for 0.68% of admissions and 30.3% of bone and joint infections during the study period. Incidence rose gradually from 2.2 new cases per year between 1966 and 1970 up to 6 to 10 new cases per year since 1991. In 88% of cases a single joint was involved, with the most commonly affected sites being the knee (32.5%), hip (22.2%), shoulder (12%) and sacroiliac joint (11.4%). Of the 22 patients with polyarticular arthritis, 19 had involvement of two joints. A portal of entry was identified in 53% of cases. Of the 13% of iatrogenic cases, half occurred after a local corticosteroid injection. The pathogen was identified in 65% of cases. Staphylococcus aureus was the most common organism (56%) followed by streptococci (9.5%) and E. coli (7%). Only three patients had gonococcal arthritis. Mean duration of therapy was four months. Although complications were exceedingly rare, three patients died and three others developed septic shock. Our data suggest that the presentation of pyogenic arthritis has remained essentially unchanged. In particular, we found no increase in iatrogenic forms, in contrast to recent experience with vertebral osteomyelitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8689280

Source DB:  PubMed          Journal:  Rev Rhum Engl Ed        ISSN: 1169-8446


  28 in total

1.  Results of treatment of septic knee arthritis: a retrospective series of 40 cases.

Authors:  Laurent Balabaud; Jeannot Gaudias; Cyril Boeri; Jean-Yves Jenny; Pierre Kehr
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-12-06       Impact factor: 4.342

2.  Septic polyarthritis caused by group A streptococcus in an immunocompetent adult: rare case.

Authors:  Assia Laatiris; Bouchra Amine; Yousra Ibn Yacoub; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2011-07-27       Impact factor: 2.631

3.  Waldenström's disease complicated by recurrent meningococcal arthritis.

Authors:  M Singwe-Ngandeu; N Buchs; P Rohner; C Gabay
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

Review 4.  Current concepts review: septic arthritis of the knee pathophysiology, diagnostics, and therapy.

Authors:  Atesch Ateschrang; Dirk Albrecht; Steffen Schroeter; Kuno Weise; Jürgen Dolderer
Journal:  Wien Klin Wochenschr       Date:  2011-04-06       Impact factor: 1.704

5.  Time delay between diagnosis and arthroscopic lavage in septic arthritis. Does it matter?

Authors:  Preetham Kodumuri; Guido Geutjens; Hui-Ling Kerr
Journal:  Int Orthop       Date:  2012-05-01       Impact factor: 3.075

6.  Unusual "flesh-eating" strains of Escherichia coli.

Authors:  Hila Shaked; Zmira Samra; Michal Paul; Liora Madar-Shapiro; Jonathan Cohen; Silvio Pitlik; Jihad Bishara
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

7.  A case report of a septic hip secondary to a psoas abscess.

Authors:  Benan M Dala-Ali; Mary-Anne Lloyd; Satish B Janipireddy; Henry D Atkinson
Journal:  J Orthop Surg Res       Date:  2010-09-16       Impact factor: 2.359

8.  Septic arthritis in adults with sickle cell disease often is associated with osteomyelitis or osteonecrosis.

Authors:  Philippe Hernigou; Gildasio Daltro; Charles-Henri Flouzat-Lachaniette; Xavier Roussignol; Alexandre Poignard
Journal:  Clin Orthop Relat Res       Date:  2009-11-03       Impact factor: 4.176

9.  A prospective study of the incidence and characteristics of septic arthritis in a teaching hospital in Riyadh, Saudi Arabia.

Authors:  Abdurahman Saud Al Arfaj
Journal:  Clin Rheumatol       Date:  2008-06-27       Impact factor: 2.980

Review 10.  Acute septic arthritis.

Authors:  Mark E Shirtliff; Jon T Mader
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.